Healthcare - Biotechnology - NASDAQ - US
$ 23.07
-1.83 %
$ 1.61 B
Market Cap
-7.25
P/E
CASH FLOW STATEMENT
85.1 M
OPERATING CASH FLOW
-111 M
INVESTING CASH FLOW
26.2 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Xencor, Inc.
| Net Income | -126 M |
| Depreciation & Amortization | 11.5 M |
| Capital Expenditures | -21.3 M |
| Stock-Based Compensation | 53.8 M |
| Change in Working Capital | 166 M |
| Others | 124 M |
| Free Cash Flow | 63.9 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (126.1) | (55.2) | 82.6 | (69.3) | 26.9 | (70.4) | (48.9) | 23.6 | (17.6) | (16.4) | (60.3) | (8.6) | (11.2) |
| Depreciation & Amortization | 11.5 | 8.8 | 7.5 | 5.8 | 4.3 | 3.3 | 2.0 | 1.5 | 1.1 | 0.9 | 0.7 | 0.5 | 0.6 |
| Deferred Income Tax | 0 | 0 | (19.0) | 9 K | 0 | 0 | 0 | 65 K | 0 | 0 | 0.2 | 0.3 | 1.1 |
| Stock Based Compensation | 53.8 | 48.9 | 37.0 | 31.6 | 31.9 | 20.5 | 13.7 | 7.8 | 4.9 | 1.9 | 0.2 | 29 K | 57 K |
| Other Operating Activities | (20.1) | (26.9) | (22.4) | (21.3) | (4.1) | 21 K | 3.3 | 2.3 | 1.4 | 0.5 | 49.8 | 1.7 | 1.8 |
| Change in Working Capital | 166.0 | 48.9 | (102.6) | 48.2 | 5.4 | (33.2) | (3.8) | 59.3 | 36.9 | (8.2) | 3.9 | (5.0) | 6.6 |
| Cash From Operations | 85.1 | 24.5 | (16.9) | (5.0) | 64.4 | (79.8) | (33.7) | 94.6 | 26.7 | (21.4) | (5.5) | (11.1) | (1.1) |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | (21.3) | (43.4) | (16.0) | (13.8) | (11.0) | (9.1) | (7.3) | (3.0) | (3.7) | (2.3) | (1.3) | (1.3) | (1.4) |
| Other Items | (89.8) | (76.3) | (30.3) | 114.0 | (39.9) | (155.6) | 39.2 | (210.6) | (181.4) | 2 K | 16 K | 97 K | 0.1 |
| Cash From Investing Activities | (111.1) | (119.7) | (46.2) | 100.2 | (51.0) | (164.8) | 31.9 | (213.7) | (185.1) | (2.3) | (1.3) | (1.2) | (1.3) |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | 2.0 | 2.1 | 0 | 1.4 | 1.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 K | 10 K | 12 K | 11 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 26.2 | 5.7 | 14.1 | 18.0 | 10.7 | (6.0) | 3.7 | (5.6) | (6.5) | 0.3 | 1.9 | 0 | 0 |
| Cash From Financing Activities | 26.2 | 5.7 | 43.0 | 18.0 | 10.7 | 254.2 | 3.7 | 121.0 | 116.4 | 0.3 | 82.4 | 12 K | 11 K |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | 0.2 | (89.5) | (20.1) | 113.2 | 24.1 | 9.7 | 2.0 | 1.9 | (42.1) | (23.3) | 75.7 | (12.2) | (2.4) |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | 63.9 | (18.9) | (32.8) | (18.8) | 53.3 | (88.9) | (41.0) | 91.6 | 23.0 | (23.6) | (6.7) | (12.3) | (2.5) |